A Role for Advanced Glycation End Products in Molecular Ageing

Int J Mol Sci. 2023 Jun 8;24(12):9881. doi: 10.3390/ijms24129881.

Abstract

Ageing is a composite process that involves numerous changes at the cellular, tissue, organ and whole-body levels. These changes result in decreased functioning of the organism and the development of certain conditions, which ultimately lead to an increased risk of death. Advanced glycation end products (AGEs) are a family of compounds with a diverse chemical nature. They are the products of non-enzymatic reactions between reducing sugars and proteins, lipids or nucleic acids and are synthesised in high amounts in both physiological and pathological conditions. Accumulation of these molecules increases the level of damage to tissue/organs structures (immune elements, connective tissue, brain, pancreatic beta cells, nephrons, and muscles), which consequently triggers the development of age-related diseases, such as diabetes mellitus, neurodegeneration, and cardiovascular and kidney disorders. Irrespective of the role of AGEs in the initiation or progression of chronic disorders, a reduction in their levels would certainly provide health benefits. In this review, we provide an overview of the role of AGEs in these areas. Moreover, we provide examples of lifestyle interventions, such as caloric restriction or physical activities, that may modulate AGE formation and accumulation and help to promote healthy ageing.

Keywords: AGE; age-related diseases; ageing; brain; caloric restriction; inflammation; oxidative stress; physical activities.

Publication types

  • Review

MeSH terms

  • Aging / metabolism
  • Chronic Disease
  • Diabetes Mellitus*
  • Glycation End Products, Advanced* / metabolism
  • Humans
  • Receptor for Advanced Glycation End Products / metabolism

Substances

  • Glycation End Products, Advanced
  • Receptor for Advanced Glycation End Products

Grants and funding

This research received no external funding.